The Exeter Group.

David L. Becker, MD founded The Exeter Group in 1992. Since then, Exeter has helped dozens of life sciences companies in the US and abroad better commercialize their products. Seconded from Exeter, Dr. Becker recently served as Commercial Lead at ExpressCells, a genetic engineering start-up focused on producing custom cell lines for drug discovery, toxicology, and other biologic research. Prior to joining ExpressCells, he was Managing Director of Catalysis Partners, providing strategic solutions in drug development and commercialization to small life sciences companies. A board-certified internist, he received his bachelor’s degree from Yale, his medical degree from NYU, and a business degree from the MIT Sloan School of Management. He is a member of the board of directors of the Society of Biomolecular Imaging and Informatics (SBI2).